IBDEI10T ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16598,0)
 ;;=D69.59^^61^775^190
 ;;^UTILITY(U,$J,358.3,16598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16598,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,16598,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,16598,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,16599,0)
 ;;=C22.7^^61^775^51
 ;;^UTILITY(U,$J,358.3,16599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16599,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,16599,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,16599,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,16600,0)
 ;;=D75.89^^61^775^61
 ;;^UTILITY(U,$J,358.3,16600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16600,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,16600,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,16600,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,16601,0)
 ;;=D47.Z9^^61^775^182
 ;;^UTILITY(U,$J,358.3,16601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16601,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,16601,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,16601,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,16602,0)
 ;;=D05.82^^61^775^39
 ;;^UTILITY(U,$J,358.3,16602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16602,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,16602,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,16602,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,16603,0)
 ;;=D05.81^^61^775^41
 ;;^UTILITY(U,$J,358.3,16603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16603,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,16603,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,16603,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,16604,0)
 ;;=D05.80^^61^775^43
 ;;^UTILITY(U,$J,358.3,16604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16604,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,16604,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,16604,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,16605,0)
 ;;=D56.8^^61^775^205
 ;;^UTILITY(U,$J,358.3,16605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16605,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,16605,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,16605,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,16606,0)
 ;;=C82.89^^61^775^81
 ;;^UTILITY(U,$J,358.3,16606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16606,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,16606,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,16606,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,16607,0)
 ;;=D51.8^^61^775^212
 ;;^UTILITY(U,$J,358.3,16607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16607,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,16607,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,16607,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,16608,0)
 ;;=I80.9^^61^775^187
 ;;^UTILITY(U,$J,358.3,16608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16608,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,16608,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,16608,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,16609,0)
 ;;=D45.^^61^775^188
 ;;^UTILITY(U,$J,358.3,16609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16609,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,16609,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,16609,2)
 ;;=^96105
